Loading...
DNLYX | FSMDX | DNLYX / FSMDX | |
Total Expense Ratio | 0.75 | 0.03 | 3,000% |
Annual Report Gross Expense Ratio | 0.84 | 0.03 | 3,360% |
Fund Existence | 8 years | 12 years | - |
Gain YTD | 7.681 | 7.598 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 405M | 25.8B | 2% |
Annual Yield % from dividends | 1.21 | 1.65 | 73% |
Returns for 1 year | -1.28 | 2.93 | -44% |
Returns for 3 years | -5.28 | 9.36 | -56% |
Returns for 5 years | -7.13 | 39.67 | -18% |
Returns for 10 years | N/A | 94.43 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ILDR | 18.35 | 0.03 | +0.16% |
First Trust Innovation Leaders ETF | |||
SBIO | 25.53 | -0.04 | -0.16% |
ALPS Medical Breakthroughs ETF | |||
RFG | 39.39 | -0.07 | -0.18% |
Invesco S&P MidCap 400® Pure Growth ETF | |||
STRAX.X | 0.993083 | -0.033045 | -3.22% |
Stratis cryptocurrency | |||
GMX.X | 48.737713 | -2.416260 | -4.72% |
GMX cryptocurrency |